Company / Income Tax per Share
Sonoma Pharmaceuticals, Inc. Income Tax per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.34
FY2026
5-year range
-$0.25 / $0.34
FY2022-FY2026
Trend
+234.0%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax per Share changed +234% YoY in FY2026, a notable deviation from the 8-year average annual change of -135%.
Based on SEC 10-K filings.
0.34 in FY2026 with a 5-year CAGR of +83.2%.
Increased from $-0.01 to $0.34 over the past 2 years.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +83.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2026, income tax per share increased 234.0% year-over-year.
- Peak income tax per share was recorded in FY2020.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $0.34 | +234.0% |
| FY2025 | -$0.25 | -3654.9% |
| FY2024 | -$0.01 | +93.8% |
| FY2023 | -$0.11 | -131.4% |
| FY2022 | $0.34 | +1988.1% |
| FY2021 | $0.02 | -95.3% |
| FY2020 | $0.35 | +377.2% |
| FY2019 | $0.07 | +107.3% |
| FY2018 | -$1.00 | - |
| FY2017 | $0.00 | - |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026